Megan Mackey

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “A Serum Proteomic Signature Predicting Survival in Patients with Glioblastoma”.

A Serum Proteomic Signature Predicting Survival in Patients with Glioblastoma

Journal of Biochemistry and Analytical studies(2020)10.16966/2576-5833.117

N/A

0DataRank · unranked

5 citations

Peter Mathen, Miller Ca, Megan Mackey, Thomas Cooley, Dee Dee Smart +3 more

Report of Canonical BCR-ABL1 Fusion in Glioblastoma

JCO Precision Oncology(2021)10.1200/po.20.00519

N/A

0DataRank · unranked

8 citations

Guangyang Yu, Madison Butler, Sivasish Sindiri, Young K. Song, Jun S. Wei +24 more

RadWise: A Rank-Based Hybrid Feature Weighting and Selection Method for Proteomic Categorization of Chemoirradiation in Patients with Glioblastoma

Cancers(2023)10.3390/cancers15102672

N/A

0DataRank · unranked

15 citations

Sarisha Jagasia, Ying Zhuge, Mary Sproull, Theresa Cooley Zgela, Megan Mackey +3 more

Revisiting Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma—Proteomic Alteration and Comparison Analysis with the Standard-of-Care Chemoirradiation

Biomolecules(2023)10.3390/biom13101499

N/A

0DataRank · unranked

14 citations

Yingdong Zhao, Ming‐Chung Li, Joanna H. Shih, Will Jiang, Erdal Taşçı +7 more

Glioblastoma survival is associated with distinct proteomic alteration signatures post chemoirradiation in a large-scale proteomic panel

Frontiers in Oncology(2023)10.3389/fonc.2023.1127645

N/A

0DataRank · unranked

11 citations

Michael Sierk, Trinh Nguyen, Qingrong Chen, Chunhua Yan, Ying Hu +9 more

MetaWise: Combined Feature Selection and Weighting Method to Link the Serum Metabolome to Treatment Response and Survival in Glioblastoma

International Journal of Molecular Sciences(2024)10.3390/ijms252010965

N/A

0DataRank · unranked

7 citations

Michael Popa, Ying Zhuge, Shreya Chappidi, Longze Zhang, Theresa Cooley Zgela +7 more

MGMT ProFWise: Unlocking a New Application for Combined Feature Selection and the Rank-Based Weighting Method to Link MGMT Methylation Status to Serum Protein Expression in Patients with Glioblastoma

International Journal of Molecular Sciences(2024)10.3390/ijms25074082

N/A

0DataRank · unranked

7 citations

Yajas Shah, Sarisha Jagasia, Ying Zhuge, Jason Shephard, Margaret Johnson +9 more

Serum CD133-Associated Proteins Identified by Machine Learning Are Connected to Neural Development, Cancer Pathways, and 12-Month Survival in Glioblastoma

Cancers(2024)10.3390/cancers16152740

N/A

0DataRank · unranked

4 citations

Erdal Taşçı, Sarisha Jagasia, Jason Shephard, Shreya Chappidi, Ying Zhuge +7 more

GLIO-Select: Machine Learning-Based Feature Selection and Weighting of Tissue and Serum Proteomic and Metabolomic Data Uncovers Sex Differences in Glioblastoma

International Journal of Molecular Sciences(2025)10.3390/ijms26094339

N/A

0DataRank · unranked

4 citations

Shreya Chappidi, Ying Zhuge, Longze Zhang, Theresa Cooley Zgela, Mary Sproull +4 more

Serum p-Cresol and 7-HOCA Levels and Fatty Acid and Purine Metabolism Are Associated with Survival, Progression, and Molecular Classification in GB—Serum Proteome and Metabolome Analysis Pre vs. Post Up-Front Chemoirradiation

Current Oncology(2025)10.3390/curroncol32110650

N/A

0DataRank · unranked

0 citations

M. Li, Yingdong Zhao, Erdal Taşçı, Shreya Chappidi, Theresa Cooley Zgela +4 more